Benjamin Seisler
About Benjamin Seisler
Data last updated:
Benjamin Seisler was a Director at Curia India Private Limited (2017–2021), Director at Amri India Private Limited (from 2017) and Director at Finekem Laboratories Private Limited (from 2017). The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Curia India Private Limited U73200TG2005PTC045178 | Director | 21 Jul 2017 | 2005 | ₹283 Cr (FY 2025) | Active |
 Amri India Private Limited U74999MH2007FTC169746 | Director | 21 Jul 2017 | 2007 | ₹53.35 Cr (FY 2017) | Amalgamated |
 Finekem Laboratories Private Limited U24110MH2003PTC139025 | Director | 21 Jul 2017 | 2003 | ₹28.16 Cr (FY 2017) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Benjamin Seisler
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Benjamin Seisler
Benjamin Seisler was first appointed on 21 Jul 2017 as Director at Curia India Private Limited.
Benjamin Seisler held 3 earlier board appointments: Curia India Private Limited (Director, 21 Jul 2017 to 15 Dec 2021); Amri India Private Limited (Director, from 21 Jul 2017); Finekem Laboratories Private Limited (Director, from 21 Jul 2017).